Chair’s opening remarks
Hear Max Bryan, Bidwells and Tim Burke, EG welcome delegates to the 2^nd Creating a Scientific Superpower conference.

Accelerating innovation as a key driver of our economic future
View this important debate on future technologies and the need for long-term strategic plans and investment, the role of universities and how we make the UK more attractive for R&D and the best scientific talent.

Baroness Nicola Blackwood, chair, Genomics England
Sir Peter Knight, senior research investigator, Imperial College London, National Quantum Strategy
Steve Rees OBE, vice-president of discovery biology, AstraZeneca
Lord David Willetts, president, Resolution Foundation, chair, UK Space Agency

Chair: Dr Barbara Ghinelli, director, innovation clusters and Harwell Campus, UKRI STFC

The power of clusters: Unleashing scientific convergence 
Sue Foxley, research director, Bidwells discusses the power of clusters.

Evolution of real estate for a new era of science and technology
This discussion focuses on defining the next generation of world-leading science, manufacturing and laboratory buildings, what is needed to build Green Labs and building science and technology real estate that benefits the community.

Emma Cariaga, joint head of Canada Water & head of residential, British Land
Jenny Gardner director of development, ARC
Artem Korolev, founder & chief executive, Mission Street
Orestis Tzortzoglou, vice president of development, Biomed Realty

Chair: Richard Todd, head of Oxford, Bidwells

In conversation with:  East West Rail as a catalyst for scientific growth
Join event chair, Tim Burke as he interviews Neil Sachdev MBE, chair, East West Railway Company.

Unleashing the Oxford-Cambridge Corridor as an engine for growth
Enjoy this debate that covers important topics such as how does the OxCam Arc maximise return on investment? Unlocking the Arc’s potential through infrastructure and the Arc’s global brand on the international stage

Richard Hutchins, managing director, Oxford to Cambridge Partnership
Neelam Patel, chief executive, Med City
Sir John Peace, chair, Midlands Engine
Dr Andy Williams, chair, Oxford-Cambridge Supercluster board

Chair: Professor Andy Neely OBE, senior pro-vice-chancellor for enterprise and business, University of Cambridge

Opening keynote:  Perspectives of a supercluster 
Sir Jonathan Symonds CBE, GSK discusses the different perspectives of a supercluster.

Keynote: Cementing the UK as a scientific superpower
The Rt Hon Chloe Smith MP, secretary of state for science, innovation and technology conducts a keynote speech.

Creating a world-class supercluster through the convergence of science and technology
Watch the discussion on how can we enable the convergence of science and technology within the Arc? Nurturing vibrant clusters to encourage collaboration and knowledge-sharing and how do we make the UK more attractive for R&D and the best scientific talent.

Katherine Morgan, head of high growth & entrepreneurs, Barclays Eagle Labs
Sharon Parker-Lines, deputy managing director & operations director, Astroscale UK
Kristin-Anne Rutter, executive director, Cambridge Biomedical Campus

Chair: Sarah Haywood, managing director, Advanced Oxford

Revaluation of science and technology: The investor outlook
This session discusses important topics such as emerging opportunities and investment outlook in science and technology, funding science and technology in the UK vs other markets and how do we fast-track the scaling of UK innovation?

Dr Glenn Crocker, executive director, Pioneer Group
Rebecca Todd, investment director, Longwall Venture Partners
Hitesh Thakrar, partner, Syncona Investment Management

Chair: Tim Burke, deputy editor, EG

Keynote: Unleashing innovation for a net zero future
Watch the Rt Hon Grant Shapps MP, secretary of state for energy security and net zero conduct the final keynote of the conference.

Breaking boundaries:  Global science and tech giants investing in the UK
Watch the final session of the day that discussed global science and tech giants offering much needed investment in the UK.

Karen Frieze, head of healthcare, life sciences & bioeconomy, investment services team, Department for Business and Trade
Greg Pada, vice-president, head of engineering business, AVEVA
Sheelpa Patel, chief marketing officer, Oxa
Professor Wolf Reik, director, Altos Labs, Cambridge Institute of Science
Professor Matthew Snape, vice-president, paediatric and maternal vaccine clinical development, Moderna

Chair: Tim Burke, deputy editor, EG